Hire Shivam Pawar, a pharma consultant specializing in Anlaytical Testing and Drug Development. See services offered, experience summary, and connect via apicule.
Based in: India
Willing to work in: Global
Consultant Type: Independent Consultant
Expertise summary: Shivam Pawar is an experienced Pharma Consultant specializing in regulatory strategy, formulation development, and quality compliance for global markets. With a strong background in pharmaceutical sciences and hands-on industry experience, Shivam supports clients through GMP audits, dossier preparation, and API–formulation alignment.
Shivam Pawar is an accomplished pharmaceutical scientist with deep expertise in analytical method development for both small molecules and complex formulations. He has extensive experience in designing and optimizing analytical methods using advanced chromatographic and spectroscopic techniques, ensuring accuracy, precision, and regulatory compliance in every stage of drug development. Shivam’s strong technical foundation and problem-solving skills enable him to address challenging analytical issues, support formulation development, and establish robust control strategies for commercial manufacturing. As an independent consultant, he now collaborates with pharmaceutical organizations to develop efficient, regulatory-compliant analytical solutions that accelerate product development and ensure consistent quality.
Shivam Pawar possesses specialized expertise in bioconjugation, with a focus on developing and characterizing antibody–drug conjugates (ADCs), peptide conjugates, and other targeted biomolecular platforms. His work integrates a deep understanding of protein chemistry, linker technologies, and analytical characterization techniques to ensure the stability, efficacy, and reproducibility of conjugated molecules. Shivam has successfully supported bioconjugation process optimization, impurity profiling, and comparability studies aligned with global regulatory expectations. As a consultant, he now helps biopharma clients design and implement robust bioconjugation strategies that bridge innovation and compliance, accelerating the development of next-generation therapeutic biologics.
